| Medical and Health Sciences | Lifetime | 369 | US 201 | 99.98 |
| Biological Sciences | Lifetime | 358 | US 207 | 99.95 |
| Philosophy, Ethics and Religion | Lifetime | 427 | US 223 | 98.95 |
| Psychiatry and Mental health | Lifetime | 26 | US 14 | 99.92 |
| Cellular and Molecular Neuroscience | Lifetime | 50 | US 34 | 99.83 |
| Clinical Pharmacology | Lifetime | 79 | US 38 | 99.67 |
| Philosophy of Mind, Language and Cognitive Science | Lifetime | 52 | US 22 | 99.38 |
| Biological Psychiatry | Lifetime | 15 | US 7 | 99.13 |
| Clinical Psychology | Lifetime | 692 | US 438 | 99.04 |
| Behavioral Neuroscience | Lifetime | 75 | US 46 | 98.21 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 593 | US 318 | 98.12 |
| Pediatrics, Perinatology and Child Health | Lifetime | 962 | US 471 | 96.64 |
| Pharmacology | Lifetime | 436 | US 190 | 95.42 |
| Clinical Neurology | Lifetime | 811 | US 369 | 95.23 |
| Psychiatry and Mental health | 2021-2025 | 550 | US 213 | 82.94 |
| Cellular and Molecular Neuroscience | 2021-2025 | 267 | US 108 | 78.21 |
| Neurotransmitter Receptor Influence on Behavior | Lifetime | 10 | US 6 | 99.90 |
| Schizophrenia research and treatment | Lifetime | 12 | US 6 | 99.91 |
| Receptor Mechanisms and Signaling | Lifetime | 34 | US 22 | 99.81 |
| Tryptophan and brain disorders | Lifetime | 21 | US 13 | 99.85 |
| Bipolar Disorder and Treatment | Lifetime | 26 | US 13 | 99.71 |
| Treatment of Major Depression | Lifetime | 22 | US 16 | 99.73 |
| Stress Responses and Cortisol | Lifetime | 83 | US 50 | 99.57 |
| Electroconvulsive Therapy Studies | Lifetime | 17 | US 9 | 99.60 |
| Neuroscience and Neuropharmacology Research | Lifetime | 293 | US 152 | 99.57 |
| Diet and metabolism studies | Lifetime | 345 | US 151 | 99.29 |
| Mental Health and Psychiatry | Lifetime | 63 | US 30 | 99.31 |
| Muscle and Compartmental Disorders | Lifetime | 46 | US 22 | 98.88 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 235 | US 101 | 98.62 |
| Genetic Neurodegenerative Diseases | Lifetime | 217 | US 93 | 98.65 |
| Neuropeptides and Animal Physiology | Lifetime | 455 | US 209 | 98.39 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 144 | US 88 | 98.47 |
| Pharmacological Receptor Mechanisms and Effects | Lifetime | 144 | US 80 | 97.49 |
| Muscle metabolism and nutrition | Lifetime | 510 | US 203 | 97.68 |
| Functional Brain Connectivity Studies | Lifetime | 799 | US 359 | 98.09 |
| Pharmacology and Obesity Treatment | Lifetime | 229 | US 105 | 97.33 |
| Adrenal Hormones and Disorders | Lifetime | 277 | US 108 | 97.11 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 351 | US 126 | 97.42 |
| Hormonal and reproductive studies | Lifetime | 700 | US 340 | 96.87 |
| Attention Deficit Hyperactivity Disorder | Lifetime | 578 | US 329 | 96.62 |
| Neurological and metabolic disorders | Lifetime | 240 | US 104 | 95.36 |
| Neuroendocrine regulation and behavior | Lifetime | 987 | US 476 | 96.18 |
| Suicide and Self-Harm Studies | Lifetime | 917 | US 456 | 93.94 |
| Biochemical Acid Research Studies | Lifetime | 866 | US 331 | 86.65 |
| Psychedelics and Drug Studies | Lifetime | 593 | US 233 | 86.59 |
| Schizophrenia research and treatment | 2021-2025 | 672 | US 145 | 89.08 |
